A COVID-19 vaccine card is a record often given to those who have received a COVID-19 vaccine showing information such as the date(s) one has received...
38 KB (3,778 words) - 07:00, 26 August 2024
A COVID‑19 vaccine is a vaccine intended to provide acquired immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus...
202 KB (22,928 words) - 23:44, 14 October 2024
The Pfizer–BioNTech COVID-19 vaccine, sold under the brand name Comirnaty, is an mRNA-based COVID-19 vaccine developed by the German biotechnology company...
260 KB (22,097 words) - 23:43, 14 October 2024
via mobile app. It may or may not use a COVID-19 vaccine card as a basis of authentication. The use of vaccine passports is based on the general presumption...
92 KB (8,779 words) - 05:08, 19 August 2024
countries, the dissemination of varied claims and perspectives regarding COVID-19 vaccines has sparked widespread public discussion. These include concerns about...
132 KB (12,898 words) - 16:08, 19 September 2024
Sanofi–GSK COVID-19 vaccine sold under the brand name VidPrevtyn Beta, is a COVID-19 vaccine developed by Sanofi Pasteur and GSK. The Sanofi–GSK COVID‑19 vaccine...
19 KB (1,436 words) - 08:53, 24 September 2024
The Janssen COVID‑19 vaccine, (Ad26.COV2.S) sold under the brand name Jcovden, is a COVID‑19 vaccine that was developed by Janssen Vaccines in Leiden,...
141 KB (11,331 words) - 06:12, 24 September 2024
Stemirna COVID-19 vaccine is a COVID-19 vaccine candidate developed by Stemirna Therapeutics. "Patent Landscape Report COVID-19-related vaccines and therapeutics"...
3 KB (113 words) - 09:01, 24 September 2024
Vaxart COVID-19 vaccine is a COVID-19 vaccine candidate developed by Vaxart. "Patent Landscape Report COVID-19-related vaccines and therapeutics" (PDF)...
2 KB (108 words) - 10:50, 24 September 2024
The Moderna COVID‑19 vaccine, sold under the brand name Spikevax, is a COVID-19 vaccine developed by the American company Moderna, the United States National...
177 KB (13,698 words) - 23:45, 14 October 2024
The Novavax COVID-19 vaccine, sold under the brand names Nuvaxovid and Covovax, among others, is a subunit COVID-19 vaccine developed by Novavax and the...
73 KB (5,521 words) - 23:45, 14 October 2024
53 billion COVID-19 vaccine doses have been administered worldwide, with 70.6 percent of the global population having received at least one dose. While 4.19 million...
156 KB (13,918 words) - 21:34, 29 September 2024
an outbreak and hasten the development of a preventive COVID-19 vaccine. Since 2020, vaccine development has been expedited via unprecedented collaboration...
122 KB (11,033 words) - 22:07, 17 July 2024
MVC-COV1901 and also known as the Medigen COVID-19 vaccine, is a protein subunit COVID-19 vaccine developed by Medigen Vaccine Biologics Corporation in Taiwan,...
15 KB (1,455 words) - 06:02, 24 September 2024
Oxford–AstraZeneca COVID‑19 vaccine, sold under the brand names Covishield and Vaxzevria among others, is a viral vector vaccine for the prevention of COVID-19. It was...
214 KB (17,080 words) - 15:51, 27 September 2024
originally termed ARCoV and also known as the Walvax COVID-19 vaccine, is an mRNA COVID-19 vaccine developed by Walvax Biotechnology, Suzhou Abogen Biosciences...
15 KB (1,451 words) - 10:24, 24 September 2024
Inovio COVID-19 vaccine is a COVID-19 vaccine candidate developed by Inovio Pharmaceuticals. In February 2020 after receiving details of the genetic sequence...
9 KB (880 words) - 06:15, 24 September 2024
COVID-19 vaccine, also known as BBIBP-CorV, the Sinopharm COVID-19 vaccine, or BIBP vaccine, is one of two whole inactivated virus COVID-19 vaccines developed...
90 KB (8,588 words) - 08:11, 24 September 2024
Valneva COVID-19 vaccine is a COVID-19 vaccine developed by French biotechnology company Valneva SE in collaboration with the American biopharmaceutical...
19 KB (1,339 words) - 09:20, 24 September 2024
Vabiotech COVID-19 vaccine is a COVID-19 vaccine candidate developed by the Vaccine and Biological Production Company No. 1 (Vabiotech) in Vietnam. In...
7 KB (668 words) - 20:53, 27 September 2023
Minhai COVID-19 vaccine (Chinese: 康泰民海新冠疫苗), trademarked as KCONVAC (Chinese: 可维克; pinyin: Kěwéikè), is a COVID-19 vaccine developed by Shenzhen Kangtai...
4 KB (321 words) - 06:04, 24 September 2024
the COVID-19 vaccine. COVID-19 vaccine hesitancy in the United States can be considered as part of the broader history of vaccine hesitancy. Vaccine hesitancy...
40 KB (3,771 words) - 01:07, 31 August 2024
for the pandemic, The Pentagon targeted China's Sinovac COVID-19 vaccine by spreading anti-vaccine misinformation in the Philippines. Information is more...
128 KB (12,009 words) - 01:40, 7 October 2024
Medical Sciences COVID-19 vaccine, or IMBCAMS COVID-19 vaccine, traded as Covidful (Chinese: 科维福; pinyin: Kēwéifú), is a COVID-19 vaccine developed by Institute...
4 KB (192 words) - 08:25, 24 September 2024
AG0302-COVID-19 is a COVID-19 vaccine candidate developed by AnGes Inc. This candidate followed a previous one called AG0301-COVID-19. "Phase I/II Study...
4 KB (172 words) - 08:15, 24 September 2024
Gam-COVID-Vac (Russian: Гам-КОВИД-Вак, the name under which it is legally registered and produced) is an adenovirus viral vector vaccine for COVID-19 developed...
154 KB (13,894 words) - 01:57, 8 October 2024
The Sinopharm WIBP COVID-19 vaccine, also known as WIBP-CorV, is one of two inactivated virus COVID-19 vaccines developed by Sinopharm. Peer-reviewed results...
11 KB (1,013 words) - 08:58, 24 September 2024
COVID-19 vaccine clinical research uses clinical research to establish the characteristics of COVID-19 vaccines. These characteristics include efficacy...
95 KB (18,965 words) - 23:35, 15 September 2024
The Sanofi–Translate Bio COVID-19 vaccine, also known as MRT5500 or VAW00001, was a COVID-19 vaccine candidate developed by Sanofi Pasteur and Translate...
5 KB (294 words) - 08:54, 24 September 2024
West China Hospital COVID-19 vaccine is a COVID-19 vaccine candidate developed by West China Hospital. In August 2020, WestVac Biopharma started phase...
4 KB (289 words) - 01:19, 13 September 2024